Abcellera Biologics Inc (ABCL)

Oct 01, 2026

AbCellera to Report Third Quarter 2026 Financial Results on November 9, 2026 - Business Wire

Oct 01, 2026

Oct 01, 2026

AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment - marketscreener.com

Oct 01, 2026

Sep 30, 2026

Total equity of AbCellera Biologics, Inc. – HAN:8QQ - TradingView

Sep 30, 2026

Sep 30, 2026

JPMorgan Initiates AbCellera Biologics at Overweight With $17 Price Target - Moomoo

Sep 30, 2026

Sep 30, 2026

AbCellera Biologics, Inc. Actuals & Estimates (HAN:8QQ) - TradingView

Sep 30, 2026

Sep 29, 2026

Why Did IOVA, ABCL, CRWD Stocks Surge To 52-Week Highs Today? - TradingView

Sep 29, 2026

Sep 29, 2026

ABCL News | ABCELLERA BIOLOGICS INC (NASDAQ:ABCL) - ChartMill

Sep 29, 2026

Sep 29, 2026

J.P. Morgan Initiates AbCellera Biologics(ABCL.US) With Buy Rating, Announces Target Price $17 - Moomoo

Sep 29, 2026

Sep 29, 2026

ABCL Initiated Coverage By JP Morgan -- Rating Set to Overweight - GuruFocus

Sep 29, 2026

Sep 29, 2026

Why is Abcellera Biologics stock climbing today? By Investing.com - Investing.com Canada

Sep 29, 2026

Sep 28, 2026

Abcellera Biologics stock hits 52-week high at 13.23 USD - Investing.com

Sep 28, 2026

Sep 24, 2026

Why Did SLS, MRNA, ABCL Stocks Surge To 52-Week Highs Last Week? - Stocktwits

Sep 24, 2026

Sep 24, 2026

Goldman Sachs Initiates AbCellera Biologics(ABCL.US) With Hold Rating, Announces Target Price $13 - moomoo.com

Sep 24, 2026

Sep 24, 2026

ABCL Reinstated by Goldman Sachs -- Neutral Rating with Price Ta - GuruFocus

Sep 24, 2026

Sep 24, 2026

AbCellera Biologics Price Target Announced at $13.00/Share by Goldman Sachs - Moomoo

Sep 24, 2026

Sep 24, 2026

Goldman Sachs resumes AbCellera stock coverage with neutral rating - Investing.com

Sep 24, 2026

Sep 24, 2026

Goldman Sachs resumes AbCellera stock coverage with neutral rating By Investing.com - Investing.com Canada

Sep 24, 2026

Sep 24, 2026

ABCL Looks 201.0% Overvalued on GF Value™ - GuruFocus

Sep 24, 2026

Sep 22, 2026

AbCellera Biologics Inc. (ABCL) Options Chain - Yahoo Finance

Sep 22, 2026

Sep 22, 2026

ABCL Stock Price and Chart — NASDAQ:ABCL - tradingview.com

Sep 22, 2026

Sep 22, 2026

ABCL Stock Surges 121% in 3 Months: Here's What You Need to Know - Yahoo Finance

Sep 22, 2026

Sep 19, 2026

ABCL Should I Buy - Intellectia AI

Sep 19, 2026

Sep 18, 2026

AbCellera Biologics Inc. (ABCL) Stock Analysis: A Biotech Gem With A 34% Upside Potential - DirectorsTalk Interviews

Sep 18, 2026

Sep 18, 2026

Biotech Stocks At 52-Week HighsMNOV +36%, PBLS +10%, ABCL +9%, HAE, NEO - RTTNews

Sep 18, 2026

Sep 17, 2026

Abcellera Biologics stock hits 52-week high at 12.58 USD By Investing.com - Investing.com Australia

Sep 17, 2026

Sep 17, 2026

Abcellera Biologics stock hits 52-week high at 12.58 USD - Investing.com

Sep 17, 2026

Sep 17, 2026

Abcellera Biologics Inc (ABCL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Sep 17, 2026

Sep 16, 2026

AbCellera to present phase 2 data on menopause treatment drug By Investing.com - Investing.com Nigeria

Sep 16, 2026

Sep 16, 2026

ABCL Looks 171.0% Overvalued on GF Value™ - gurufocus.com

Sep 16, 2026

Sep 16, 2026

AbCellera Announces Presentation of Phase 2 Data for ABCL635 at the IMS World Congress on Menopause 2026 - Investing News Network

Sep 16, 2026

Sep 16, 2026

AbCellera to present phase 2 data on menopause treatment drug - Investing.com

Sep 16, 2026

Sep 10, 2026

AbCellera at Cantor healthcare conference: nk3r drug boosts hopes By Investing.com - Investing.com South Africa

Sep 10, 2026

Sep 09, 2026

AbCellera at Cantor healthcare conference: nk3r drug boosts hopes - Investing.com

Sep 09, 2026

Sep 09, 2026

AbCellera to Present at the Cantor Global Healthcare Conference on September 9, 2026 - Investing News Network

Sep 09, 2026

Sep 05, 2026

symbol__ Stock Quote Price and Forecast - CNN

Sep 05, 2026

Sep 02, 2026

Truist Financial Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Maintains Target Price $30 - Moomoo

Sep 02, 2026

Aug 27, 2026

AbCellera Biologics (ABCL) Q4 2025 Earnings: Results, Market Reaction & History - 24/7 Wall St.

Aug 27, 2026

Aug 26, 2026

AbCellera Biologics Stock (ABCL) Opinions on Recent Surge and Insider Buying - Quiver Quantitative

Aug 26, 2026

Aug 26, 2026

Historical Data for AbCellera Biologics Inc. Tokenized Stock (Robinhood) in USD - CryptoRank

Aug 26, 2026

Aug 25, 2026

What'sGoing On With AbCellera Biologics Stock On Tuesday? - Benzinga

Aug 25, 2026

Aug 25, 2026

ABCL Stock Surges As ABCL635 Data Reset Wall Street Expectations - StocksToTrade

Aug 25, 2026

Aug 22, 2026

Are Medical Stocks Lagging ABCELLERA BIOLG (ABCL) This Year? - Eastern Progress

Aug 22, 2026

Aug 20, 2026

ABCL StockAbCellera Biologics Inc Stock Breaking News Today | ABCL Stock Price Punaises (dD09m2oJ3D) - Mshale

Aug 20, 2026

Aug 19, 2026

AbCellera Biologics (ABCL) Reports Phase 2 Success, Is It Still A Bargain? - simplywall.st

Aug 19, 2026

Aug 18, 2026

Abcellera director John S. Montalbano acquires common shares worth $110,300 - Bitget

Aug 18, 2026

Aug 18, 2026

AbCellera Biologics Director John S. Montalbano Acquires 10,000 Shares on August 18, 2026 - Kalkine Media

Aug 18, 2026

Aug 18, 2026

AbCellera Biologics | 4: Statement of changes in beneficial ownership of securities-Director Montalbano John S. - Moomoo

Aug 18, 2026